Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
Clinical trial NCT04400331 · COMPLETED
Trial details
- NCT number
- NCT04400331
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2025-11-05
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.